Home > Healthcare > Medical Devices > Diagnostic Devices > Hemodynamic Monitoring Devices Market

Hemodynamic Monitoring Devices Market Size

  • Report ID: GMI7995
  • Published Date: Oct 2024
  • Report Format: PDF

Hemodynamic Monitoring Devices Market Size

The global hemodynamic monitoring devices market size was valued at around USD 1.4 billion in 2023 and is estimated to grow at 6.7% CAGR from 2024 to 2032. Hemodynamic monitoring devices are medical instruments used to assess and track the cardiovascular system's performance, specifically blood flow and pressure within the circulatory system.

 

These devices provide real-time data on key physiological parameters, such as cardiac output, blood pressure, oxygenation levels, and vascular resistance, enabling healthcare providers to evaluate heart function and fluid balance. The rising prevalence of cardiovascular conditions, including heart disease and hypertension, is driving the demand for these devices. Hemodynamic monitoring devices are critical for assessing cardiac function and guiding treatment, making them indispensable for managing both chronic and acute cardiovascular conditions.
 

For example, the U.S. Centers for Disease Control and Prevention (CDC) reports that heart disease is the leading cause of death across genders and most racial and ethnic groups. Cardiovascular disease claims a life every 33 seconds, with heart disease alone causing 702,880 deaths in 2022, representing about 20% of all deaths in the U.S. Among these, coronary heart disease accounted for 371,506 deaths. As a result, the growing patient population requiring detailed monitoring and management is expected to boost the demand for advanced hemodynamic monitoring solutions, driving market growth.
 

Additionally, advancements in technology, such as the development of non-invasive and minimally invasive monitoring devices, are improving patient comfort and data accuracy, further fueling market growth.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global hemodynamic monitoring devices industry was valued at around USD 1.4 billion in 2023 and is estimated to grow at a 6.7% CAGR from 2024 to 2032, driven by the increasing need for cardiovascular system assessment tools.

The disposables segment dominated the market with a revenue of USD 437.9 million in 2023, as single-use items are crucial in minimizing the risk of cross-contamination and hospital-acquired infections (HAIs).

North American market for hemodynamic monitoring devices recorded USD 470.5 million in 2023 and is forecasted to reach USD 888.1 million by 2032, driven by the rising prevalence of chronic diseases.

Key players in the industry include Abbott Laboratories, Baxter International, Canon Medical Systems Corporation, Deltex Medical Group, Edwards Lifesciences Corporation, GE HealthCare Technologies, Getinge, ICU Medical, and Koninklijke Philips N.V.

Hemodynamic Monitoring Devices Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 130
  • Countries covered: 18
  • Pages: 140
 Download Free Sample